← Back to Search

Other

3804-250A lotion for Common Cold

Phase 2
Waitlist Available
Led By Ronald Turner, MD
Research Sponsored by The Dial Corporation
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be between 18 and 65 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 9 weeks
Awards & highlights

Study Summary

The purpose of this of this study is to determine if 3804-250A can prevent the common cold caused by the rhinovirus when applied to the hands. The study will also evaluate whether 3804-250A can prevent rhinovirus infection or common cold illnesses. The study will also evaluate the safety of 3804-250A.

Eligible Conditions
  • Common Cold
  • Healthy Subjects

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~9 weeks
This trial's timeline: 3 weeks for screening, Varies for treatment, and 9 weeks for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Reduction of rhinovirus-induced common colds.
Secondary outcome measures
Reduction of rhinovirus infections and reduction of common colds.

Side effects data

From 2008 Phase 2 trial • 411 Patients • NCT00762476
8%
Skin laceration
6%
Excoriation
4%
thermal burn
3%
Application site pruritus
3%
Scratch
3%
Headache
2%
Application site vesicles
1%
Open wound
100%
80%
60%
40%
20%
0%
Study treatment Arm
3804-250A
Placebo

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: 3804-250A lotionExperimental Treatment1 Intervention
Group II: No treatmentActive Control1 Intervention
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
3804-250A
2008
Completed Phase 2
~420

Find a Location

Who is running the clinical trial?

The Dial CorporationLead Sponsor
1 Previous Clinical Trials
411 Total Patients Enrolled
1 Trials studying Common Cold
411 Patients Enrolled for Common Cold
Hill Top ResearchIndustry Sponsor
2 Previous Clinical Trials
714 Total Patients Enrolled
1 Trials studying Common Cold
411 Patients Enrolled for Common Cold
Ronald Turner, MDPrincipal InvestigatorUniversity of Virginia
2 Previous Clinical Trials
835 Total Patients Enrolled
1 Trials studying Common Cold
789 Patients Enrolled for Common Cold

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Recent research and studies
clinicaltrials.govStudy
Efficacy Study of A Lotion to Prevent Common Colds
2009. "Efficacy Study of A Lotion to Prevent Common Colds". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT00993759.
All > Common Cold
~14 spots leftby Apr 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top